The 2025 Asian Pacific Longevity Medicine International Summit (APAC-LMIS), scheduled for October 4-5 in Hong Kong, aims to unite scientists, clinicians, biotech startups, and investors from around the world to promote evidence-based, ethical longevity medicine in clinical settings.

This summit marks the first in a series of international meetings dedicated to advancing longevity medicine and enhancing healthspan globally.

APAC-LMIS emphasizes peer-reviewed research and proven approaches, setting itself apart from biohacking trends and commercial claims.

The event will feature representation from over 30 countries, covering more than half of the global population, with a focus on super-aging societies like Japan, Hong Kong, and Singapore.

Attendees will have access to science-based solutions, training programs for healthcare providers, showcases of successful longevity models, and testing of non-medical longevity solutions in a dedicated living lab.

A key objective of the summit is to establish longevity medicine as a trusted medical specialty by setting standards, maintaining scientific rigor, and shaping future clinical practices.

The summit will also feature the Top 10 Longevity Breakthrough Awards, highlighting promising innovations for both clinical and home use.